Birt-hogg-dube Syndrome
What's New
Last Posted: Oct 14, 2021
- Birt-Hogg-Dubé Syndrome and Hereditary Leiomyomatosis and Renal Cell Carcinoma Syndrome: An Effective Multidisciplinary Approach to Hereditary Renal Cancer Predisposing Syndromes.
Al-Shinnag Mohammad et al. Frontiers in oncology 2021 11738822 - Colorectal cancer risk in families with Birt-Hogg-Dubé syndrome increased.
Sattler Elke C et al. European journal of cancer (Oxford, England : 1990) 2021 151168-174 - Structured assessment and followup for patients with hereditary kidney tumour syndromes.
Lattouf Jean-Baptiste et al. Canadian Urological Association journal = Journal de l'Association des urologues du Canada 10(7-8) E214-E222 - Clinical and morphologic review of 60 hereditary renal tumors from 30 hereditary renal cell carcinoma syndrome patients: lessons from a contemporary single institution series.
Kennedy John M et al. Medical oncology (Northwood, London, England) 2019 Jul 36(9) 74 - The Relevance of Family History Taking in the Detection and Management of Birt-Hogg-Dubé Syndrome.
Torricelli Elena et al. Respiration; international review of thoracic diseases 2019 Jul 1-8 - Role of Radiologists in the Diagnosis of Unsuspected Birt-Hogg-Dubé Syndrome in a Tertiary Clinical Practice.
Lee Elizabeth et al. AJR. American journal of roentgenology 2019 May 1-6 - New Study Explains Why Genetic Mutations Cause Disease in Some People but Not in Others
Columbia Systems Biology News, August 2018 - CLINGEN Actionability Report for Birt-Hogg-Dub� syndrome - FLCN
ClinGen Actionability Working Group - CLINGEN Actionability Report for Familial papillary renal cell carcinoma 1 - MET
ClinGen Actionability Working Group - Hereditary renal cell carcinoma syndromes: diagnosis, surveillance and management.
Maher Eamonn R et al. World journal of urology 2018 Apr
More
About Rare Diseases PHGKB
Rare Disease PHGKB is an online, continuously updated, searchable database of published scientific literature, CDC and NIH resources, and other information that address the public health impact and translation of genomic and other precision health discoveries into improved health outcomes related to rare diseases...more
Content Summary
Selected Rare Diseases
- Alpha-1 Antitrypsin Deficiency
- Amyotrophic Lateral Sclerosis
- Brugada Syndrome
- Cerebral Palsy
- Cystic Fibrosis
- Duchenne Muscular Dystrophy
- Eclampsia
- Erythema Multiforme
- Familial Mediterranean Fever
- Fragile X Syndrome
- Gaucher Disease
- Glomerulonephritis
- Graves Disease
- Hemophilia
- Huntington Disease
- Microcephaly
- Myasthenia Gravis
- Phenylketonuria
- Retinitis Pigmentosa
- Severe Combined Immunodeficiency
Disclaimer: Articles listed in the Public Health Knowledge Base are selected by Public Health Genomics Branch to provide current awareness of the literature and news. Inclusion in the update does not necessarily represent the views of the Centers for Disease Control and Prevention nor does it imply endorsement of the article's methods or findings. CDC and DHHS assume no responsibility for the factual accuracy of the items presented. The selection, omission, or content of items does not imply any endorsement or other position taken by CDC or DHHS. Opinion, findings and conclusions expressed by the original authors of items included in the update, or persons quoted therein, are strictly their own and are in no way meant to represent the opinion or views of CDC or DHHS. References to publications, news sources, and non-CDC Websites are provided solely for informational purposes and do not imply endorsement by CDC or DHHS.
- Page last reviewed:Feb 1, 2024
- Page last updated:May 08, 2024
- Content source: